Nave KA - Search Results

1

Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.

Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, Graudens E, Mandel J, Laffaire J, Foucquier J, Glibert F, Bertrand V, Nave KA, Sereda MW, Vial E, Guedj M, Hajj R, Nabirotchkin S, Cohen D. Chumakov I, et al. Among authors: nave ka. Orphanet J Rare Dis. 2014 Dec 10;9:201. doi: 10.1186/s13023-014-0201-x. Orphanet J Rare Dis. 2014. PMID: 25491744 Free PMC article.

2

Mouse models of myelin diseases.

Werner H, Jung M, Klugmann M, Sereda M, Griffiths IR, Nave KA. Werner H, et al. Among authors: nave ka. Brain Pathol. 1998 Oct;8(4):771-93. doi: 10.1111/j.1750-3639.1998.tb00200.x. Brain Pathol. 1998. PMID: 9804383 Free PMC article. Review.

3

The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.

Niemann S, Sereda MW, Rossner M, Stewart H, Suter U, Meinck HM, Griffiths IR, Nave KA. Niemann S, et al. Among authors: nave ka. Ann N Y Acad Sci. 1999 Sep 14;883:254-61. Ann N Y Acad Sci. 1999. PMID: 10586250 Review.

4

Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22.

Niemann S, Sereda MW, Suter U, Griffiths IR, Nave KA. Niemann S, et al. Among authors: nave ka. J Neurosci. 2000 Jun 1;20(11):4120-8. doi: 10.1523/JNEUROSCI.20-11-04120.2000. J Neurosci. 2000. PMID: 10818147 Free PMC article.

5

The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells.

Schneider S, Bosse F, D'Urso D, Muller H, Sereda MW, Nave K, Niehaus A, Kempf T, Schnolzer M, Trotter J. Schneider S, et al. J Neurosci. 2001 Feb 1;21(3):920-33. doi: 10.1523/JNEUROSCI.21-03-00920.2001. J Neurosci. 2001. PMID: 11157078 Free PMC article.

6

Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).

Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA. Sereda MW, et al. Among authors: nave ka. Nat Med. 2003 Dec;9(12):1533-7. doi: 10.1038/nm957. Epub 2003 Nov 9. Nat Med. 2003. PMID: 14608378

7

Axonal neuregulin-1 regulates myelin sheath thickness.

Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA. Michailov GV, et al. Among authors: nave ka. Science. 2004 Apr 30;304(5671):700-3. doi: 10.1126/science.1095862. Epub 2004 Mar 25. Science. 2004. PMID: 15044753

8

Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease.

Grandis M, Leandri M, Vigo T, Cilli M, Sereda MW, Gherardi G, Benedetti L, Mancardi G, Abbruzzese M, Nave KA, Nobbio L, Schenone A. Grandis M, et al. Among authors: nave ka. Exp Neurol. 2004 Nov;190(1):213-23. doi: 10.1016/j.expneurol.2004.07.008. Exp Neurol. 2004. PMID: 15473994

9

Experimental Charcot-Marie-Tooth type 1A: a cDNA microarrays analysis.

Vigo T, Nobbio L, Hummelen PV, Abbruzzese M, Mancardi G, Verpoorten N, Verhoeven K, Sereda MW, Nave KA, Timmerman V, Schenone A. Vigo T, et al. Among authors: nave ka. Mol Cell Neurosci. 2005 Apr;28(4):703-14. doi: 10.1016/j.mcn.2004.11.016. Mol Cell Neurosci. 2005. PMID: 15797717

10

Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy.

Meyer zu Hörste G, Prukop T, Nave KA, Sereda MW. Meyer zu Hörste G, et al. Among authors: nave ka. J Mol Neurosci. 2006;28(1):77-88. doi: 10.1385/jmn:28:1:77. J Mol Neurosci. 2006. PMID: 16632877 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters